Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors

Detalhes bibliográficos
Autor(a) principal: Guglielmino, Grazzia
Data de Publicação: 2019
Outros Autores: Moraes, Bruno Teixeira de, Villanova, Luiz Celso, Padovani, Marina, De Biase, Noemi Grigoletto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/154705
Resumo: OBJECTIVES: Vocal tremors, which cause social difficulties for patients, may be classified as resting or action tremors. Of the vocal action tremors, essential and dystonic tremors are the most common. Botulinum toxin and oral medications have been used to treat vocal tremors, but no comparative clinical trials have been performed. The aim of this study was to compare the effects of botulinum toxin injection and the oral administration of propranolol in the treatment of essential and dystonic vocal tremors. METHODS: This clinical trial recruited 15 patients, divided into essential and dystonic vocal tremor groups. Patients in both groups received successive treatment with botulinum toxin and propranolol. The treatments were administered at different times; the order of treatment was randomly selected. Patients were assessed with flexible nasofibrolaryngoscopy and with perceptual and acoustic voice evaluations. A statistical significance level of 0.05 (5%) was used. RESULTS: Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol. The acoustic measure of variability in the fundamental frequency was significantly lower in patients with dystonic vocal tremors after treatment with botulinum toxin. CONCLUSION: Essential and dystonic vocal tremors responded differently to treatment. Dystonic vocal tremors responded significantly to treatment with botulinum toxin but not oral propranolol. Essential vocal tremors did not respond significantly to either treatment, perhaps due to the small number of patients, which is a limitation of this research.
id USP-19_9cf5306e7c4fc39539e9822c100130fb
oai_identifier_str oai:revistas.usp.br:article/154705
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremorsBotulinum ToxinPropranololVocal TremorTreatment OutcomeDystonic TremorOBJECTIVES: Vocal tremors, which cause social difficulties for patients, may be classified as resting or action tremors. Of the vocal action tremors, essential and dystonic tremors are the most common. Botulinum toxin and oral medications have been used to treat vocal tremors, but no comparative clinical trials have been performed. The aim of this study was to compare the effects of botulinum toxin injection and the oral administration of propranolol in the treatment of essential and dystonic vocal tremors. METHODS: This clinical trial recruited 15 patients, divided into essential and dystonic vocal tremor groups. Patients in both groups received successive treatment with botulinum toxin and propranolol. The treatments were administered at different times; the order of treatment was randomly selected. Patients were assessed with flexible nasofibrolaryngoscopy and with perceptual and acoustic voice evaluations. A statistical significance level of 0.05 (5%) was used. RESULTS: Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol. The acoustic measure of variability in the fundamental frequency was significantly lower in patients with dystonic vocal tremors after treatment with botulinum toxin. CONCLUSION: Essential and dystonic vocal tremors responded differently to treatment. Dystonic vocal tremors responded significantly to treatment with botulinum toxin but not oral propranolol. Essential vocal tremors did not respond significantly to either treatment, perhaps due to the small number of patients, which is a limitation of this research.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-02-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/15470510.6061/clinics/2018/e87Clinics; Vol. 73 (2018); e87Clinics; v. 73 (2018); e87Clinics; Vol. 73 (2018); e871980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/154705/150759Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessGuglielmino, GrazziaMoraes, Bruno Teixeira deVillanova, Luiz CelsoPadovani, MarinaDe Biase, Noemi Grigoletto2019-05-14T11:48:50Zoai:revistas.usp.br:article/154705Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-14T11:48:50Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
title Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
spellingShingle Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
Guglielmino, Grazzia
Botulinum Toxin
Propranolol
Vocal Tremor
Treatment Outcome
Dystonic Tremor
title_short Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
title_full Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
title_fullStr Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
title_full_unstemmed Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
title_sort Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors
author Guglielmino, Grazzia
author_facet Guglielmino, Grazzia
Moraes, Bruno Teixeira de
Villanova, Luiz Celso
Padovani, Marina
De Biase, Noemi Grigoletto
author_role author
author2 Moraes, Bruno Teixeira de
Villanova, Luiz Celso
Padovani, Marina
De Biase, Noemi Grigoletto
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Guglielmino, Grazzia
Moraes, Bruno Teixeira de
Villanova, Luiz Celso
Padovani, Marina
De Biase, Noemi Grigoletto
dc.subject.por.fl_str_mv Botulinum Toxin
Propranolol
Vocal Tremor
Treatment Outcome
Dystonic Tremor
topic Botulinum Toxin
Propranolol
Vocal Tremor
Treatment Outcome
Dystonic Tremor
description OBJECTIVES: Vocal tremors, which cause social difficulties for patients, may be classified as resting or action tremors. Of the vocal action tremors, essential and dystonic tremors are the most common. Botulinum toxin and oral medications have been used to treat vocal tremors, but no comparative clinical trials have been performed. The aim of this study was to compare the effects of botulinum toxin injection and the oral administration of propranolol in the treatment of essential and dystonic vocal tremors. METHODS: This clinical trial recruited 15 patients, divided into essential and dystonic vocal tremor groups. Patients in both groups received successive treatment with botulinum toxin and propranolol. The treatments were administered at different times; the order of treatment was randomly selected. Patients were assessed with flexible nasofibrolaryngoscopy and with perceptual and acoustic voice evaluations. A statistical significance level of 0.05 (5%) was used. RESULTS: Botulinum toxin produced statistically significant improvements in perceptual measures of vocal instability in patients with dystonic vocal tremors compared with baseline values and treatment with propranolol. The acoustic measure of variability in the fundamental frequency was significantly lower in patients with dystonic vocal tremors after treatment with botulinum toxin. CONCLUSION: Essential and dystonic vocal tremors responded differently to treatment. Dystonic vocal tremors responded significantly to treatment with botulinum toxin but not oral propranolol. Essential vocal tremors did not respond significantly to either treatment, perhaps due to the small number of patients, which is a limitation of this research.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154705
10.6061/clinics/2018/e87
url https://www.revistas.usp.br/clinics/article/view/154705
identifier_str_mv 10.6061/clinics/2018/e87
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/154705/150759
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 73 (2018); e87
Clinics; v. 73 (2018); e87
Clinics; Vol. 73 (2018); e87
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222763728764928